易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002826 易明医药

已收盘 07-10 15:00:00

{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":17.97,"timestamp":1752131010000,"preClose":18.4,"halted":0,"volume":11823882,"delay":0,"changeRate":-0.0234,"floatShares":174000000,"shares":191000000,"eps":0.1932,"marketStatus":"已收盘","change":-0.43,"latestTime":"07-10 15:00:00","open":18.4,"high":18.44,"low":17.93,"amount":214000000,"amplitude":0.0277,"askPrice":17.97,"askSize":170,"bidPrice":17.96,"bidSize":38,"shortable":0,"etf":0,"ttmEps":0.1932,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752197400000},"marketStatusCode":5,"adr":0,"adjPreClose":18.4,"symbolType":"stock","openAndCloseTimeList":[[1752111000000,1752118200000],[1752123600000,1752130800000]],"highLimit":20.24,"lowLimit":16.56,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":4.61,"roa":"--","peRate":93.012422,"roe":"2.51%","epsLYR":0.25,"committee":0.407091,"marketValue":3426000000,"turnoverRate":0.0678,"status":1,"floatMarketCap":3133000000},"requestUrl":"/m/hq/s/002826","defaultTab":"news","newsList":[{"id":"2550685411","title":"易明医药：截至2025年6月30日股东数为22,007户","url":"https://stock-news.laohu8.com/highlight/detail?id=2550685411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550685411?lang=zh_cn&edition=full","pubTime":"2025-07-09 15:34","pubTimestamp":1752046474,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)07月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止于2025年7.8日收盘公司股东人数数量易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司最新下发的股东名册，截至2025年6月30日，本公司股东数为22,007户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070900020140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0239","BK0056"],"gpt_icon":0},{"id":"2548831803","title":"易明医药：截至2025年6月30日股东数为22,007户","url":"https://stock-news.laohu8.com/highlight/detail?id=2548831803","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548831803?lang=zh_cn&edition=full","pubTime":"2025-07-02 08:52","pubTimestamp":1751417533,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：截止6.30股东人数 易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2025年6月30日，本公司股东数为22,007户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200006316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","BK0239","002826"],"gpt_icon":0},{"id":"2547094784","title":"易明医药：6月27日高管周战减持股份合计168万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2547094784","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547094784?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:02","pubTimestamp":1751288525,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月30日市场公开信息、上市公司公告及交易所披露数据整理，易明医药（002826）最新董监高及相关人员股份变动情况：2025年6月27日公司董事周战共减持公司股份168.0万股，占公司总股本为0.8811%。变动期间公司股价下跌6.88%，6月27日当日收盘报19.21元。易明医药近半年内的董监高及核心技术人员增减持详情如下：易明医药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025063000032149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0239","BK0056"],"gpt_icon":0},{"id":"2546779080","title":"6月27日易明医药跌6.88%，诺安多策略混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2546779080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546779080?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:28","pubTimestamp":1751012890,"startTime":"0","endTime":"0","summary":"证券之星消息，6月27日易明医药跌6.88%，收盘报19.21元，换手率18.57%，成交量32.38万手，成交额6.29亿元。重仓易明医药的公募基金请见下表：根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为诺安基金的诺安多策略混合A。诺安多策略混合A目前规模为5.93亿元，最新净值2.659，较上一交易日下跌0.04%，近一年上涨95.08%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700026676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","BK0056","002826","160921"],"gpt_icon":0},{"id":"2546935682","title":"异动快报：易明医药（002826）6月25日14点50分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2546935682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546935682?lang=zh_cn&edition=full","pubTime":"2025-06-25 14:55","pubTimestamp":1750834522,"startTime":"0","endTime":"0","summary":"证券之星6月25日盘中消息，14点50分易明医药触及跌停板。目前价格20.72，下跌9.99%。其所属行业化学制药目前下跌。领涨股为多瑞医药。该股为西藏概念，医药，中药概念热股，当日西藏概念概念上涨0.01%。6月25日的资金流向数据方面，主力资金净流入6503.98万元，占总成交额11.53%，游资资金净流出6512.73万元，占总成交额11.55%，散户资金净流入8.75万元，占总成交额0.02%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062500018749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0056","BK0239"],"gpt_icon":0},{"id":"2544148227","title":"A股异动丨易明医药一度跌逾5% 股东周战累计减持1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2544148227","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544148227?lang=zh_cn&edition=full","pubTime":"2025-06-20 15:00","pubTimestamp":1750402802,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2544294164","title":"易明医药：6月18日高管周战减持股份合计5.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2544294164","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544294164?lang=zh_cn&edition=full","pubTime":"2025-06-19 21:01","pubTimestamp":1750338106,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月19日市场公开信息、上市公司公告及交易所披露数据整理，易明医药（002826）最新董监高及相关人员股份变动情况：2025年6月18日公司董事周战共减持公司股份5.85万股，占公司总股本为0.0307%。变动期间公司股价下跌3.32%，6月18日当日收盘报23.58元。易明医药近半年内的董监高及核心技术人员增减持详情如下：易明医药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061900034301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","BK0239","002826"],"gpt_icon":0},{"id":"2544970897","title":"易明医药：6月17日高管周战减持股份合计184.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2544970897","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544970897?lang=zh_cn&edition=full","pubTime":"2025-06-18 21:01","pubTimestamp":1750251703,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月18日市场公开信息、上市公司公告及交易所披露数据整理，易明医药（002826）最新董监高及相关人员股份变动情况：2025年6月17日公司董事周战共减持公司股份184.8万股，占公司总股本为0.9692%。变动期间公司股价上涨4.23%，6月17日当日收盘报24.39元。易明医药近半年内的董监高及核心技术人员增减持详情如下：易明医药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800035786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0033","BK0056"],"gpt_icon":0},{"id":"2544672179","title":"易明医药：公司未收到周战先生针对其股份减持进展的信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2544672179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544672179?lang=zh_cn&edition=full","pubTime":"2025-06-17 20:51","pubTimestamp":1750164679,"startTime":"0","endTime":"0","summary":"高管周战计划减持公司股票，2025/6/30日截止，请问是否减持完毕或是否有提前终止的打算易明医药回复：尊敬的投资者您好，公司于2025年3月10日披露了《关于公司董事、持有5%以上股东减持股份的预披露公告》，减持期间为自减持预披露公告披露之日起15个交易日后的3个月内完成。截至目前，公司未收到周战先生针对其股份减持进展的信息，若有，公司将根据相关法规及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061700034668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0056","BK0239"],"gpt_icon":0},{"id":"2544951363","title":"6月17日易明医药创60日新高，诺安多策略混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2544951363","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544951363?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:26","pubTimestamp":1750148818,"startTime":"0","endTime":"0","summary":"证券之星消息，6月17日易明医药创60日新高，收盘报24.39元，当日涨4.23%，换手率27.75%，成交量48.37万手，成交额11.38亿元。重仓易明医药的公募基金请见下表：根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为诺安基金的诺安多策略混合A。诺安多策略混合A目前规模为5.93亿元，最新净值2.614，较上一交易日上涨1.12%，近一年上涨92.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061700024256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["160921","BK0239","BK0056","002826","BK0033"],"gpt_icon":0},{"id":"2543962958","title":"易明医药：公司控制权变更事项目前按相关法规和股权转让协议的规定正在进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2543962958","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543962958?lang=zh_cn&edition=full","pubTime":"2025-06-16 16:15","pubTimestamp":1750061720,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司实控人更换后会不会改变上市公司名称？比如58安居客医药之类的易明医药回复：尊敬的投资者您好，公司控制权变更事项目前按相关法规和股权转让协议的规定正在进行中，该事项能否最终实施完成及实施结果尚存在不确定性，请注意投资风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061600018397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0033","BK0239"],"gpt_icon":0},{"id":"2542545374","title":"重磅利好落地，易明医药连续六日涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2542545374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542545374?lang=zh_cn&edition=full","pubTime":"2025-06-11 13:53","pubTimestamp":1749621212,"startTime":"0","endTime":"0","summary":"截至发稿，该公司股价已连续六日涨停，成交额达1.86亿元，换手率4.94%，市场关注度持续攀升。消息面上，此次股价异动或与公司控股股东的股权变动密切相关。从公司的营业收入构成来看，米格列醇片是其核心产品。据公司介绍，米格列醇片为国内首仿药物，2020年4月首批通过一致性评价，2021年6月在第五批国家集采中中标。截至报告期末，米格列醇片已在全国25个省份实现中标，2022年至2024年间连续三年保持营收增长，展现出强劲的市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025061100016426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","002826"],"gpt_icon":0},{"id":"2542322151","title":"西藏板块盘中拉升，易明医药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2542322151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542322151?lang=zh_cn&edition=full","pubTime":"2025-06-11 09:48","pubTimestamp":1749606486,"startTime":"0","endTime":"0","summary":"06月11日，西藏板块盘中拉升，截至09点48分，西藏板块整体指数上涨1.03%，报2073.120点。从个股上来看，该板块的成分股中，易明医药涨停，奇正藏药、恩威医药、西藏天路涨幅居前。从资金上来看，截止发稿，西藏板块主力净流入为1148.86万，其中易明医药受到资金热捧，主力净流入2809.71万；拉长时间线来看，该板块近20日主力资金净流入-19.13亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611094806a702e3fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611094806a702e3fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0101","BK0239","BK0139","BK0056","002826","BK0033","BK0188","600326","BK0235"],"gpt_icon":0},{"id":"2542322149","title":"6月11日集合竞价：易明医药6连板 北矿科技3连板","url":"https://stock-news.laohu8.com/highlight/detail?id=2542322149","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542322149?lang=zh_cn&edition=full","pubTime":"2025-06-11 09:26","pubTimestamp":1749605181,"startTime":"0","endTime":"0","summary":"6月11日，三大指数集体高开，上证指数高开0.02%，深证成指高开0.14%，创业板指高开0.34%。板块方面，汽车零部件领涨，美晨科技涨13.87%，医药商业、中药等开盘涨幅居前。个股方面，9股竞价涨停，其中易明医药6连板、北矿科技3连板、苏州龙杰3连板、新筑股份2连板、曲江文旅2连板。免责声明：本文基于AI生产，仅供参考，不构成任何投资建议，据此操作风险自担。（文章来源：东方财富研究中心）文章来源：东方财富研究中心","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061109292395170549&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061109292395170549&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600980","BK0239","BK0086","BK0214","BK0033","BK0010","BK0251","002826","BK0084","BK0056"],"gpt_icon":0},{"id":"2542439419","title":"6月10日易明医药（002826）龙虎榜数据：游资上海松林路、宁波桑田路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2542439419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542439419?lang=zh_cn&edition=full","pubTime":"2025-06-10 17:13","pubTimestamp":1749546811,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年6月10日公布的交易公开信息显示，易明医药因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年6月10日收盘，易明医药报收于19.61元，上涨9.98%，已连续涨停5天，换手率3.81%，成交量6.59万手，成交额1.29亿元。从龙虎榜公布的三日买卖数据来看，上海松林路、宁波桑田路等知名游资榜上有名。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061000026124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","BK0056","002826"],"gpt_icon":0},{"id":"2542912443","title":"5连板易明医药：股份转让协议事项能否最终实施完成及实施结果尚存在不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2542912443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542912443?lang=zh_cn&edition=full","pubTime":"2025-06-10 17:08","pubTimestamp":1749546489,"startTime":"0","endTime":"0","summary":"易明医药公告称，公司股票于2025年6月9日、6月10日连续两个交易日内收盘价涨幅偏离值累计达到20％以上，属于股票交易异常波动情况。本次权益变动事项尚需取得深圳证券交易所的合规性确认意见并在中国证券登记结算公司深圳分公司办理股份过户登记手续以及完成相关法律法规要求可能涉及的其他批准，该事项能否最终实施完成及实施结果尚存在不确定性，敬请投资者注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061000025878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","002826","BK0033"],"gpt_icon":0},{"id":"2542809000","title":"6月9日易明医药涨9.99%，诺安多策略混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2542809000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542809000?lang=zh_cn&edition=full","pubTime":"2025-06-09 16:29","pubTimestamp":1749457786,"startTime":"0","endTime":"0","summary":"证券之星消息，6月9日易明医药涨9.99%创60日新高，收盘报17.83元，换手率0.58%，成交量9995.0手，成交额1782.18万元。重仓易明医药的公募基金请见下表：根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为诺安基金的诺安多策略混合A。诺安多策略混合A目前规模为5.93亿元，最新净值2.581，较上一交易日上涨0.9%，近一年上涨103.07%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900020216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","160921","BK0056","BK0239","002826"],"gpt_icon":0},{"id":"2542873853","title":"中药股开盘拉升，易明医药、众生药业双双涨停，精华制药、沃华医药、启迪药业、康惠制药等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542873853","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542873853?lang=zh_cn&edition=full","pubTime":"2025-06-09 09:36","pubTimestamp":1749433009,"startTime":"0","endTime":"0","summary":"中药股开盘拉升，易明医药、众生药业双双涨停，精华制药、沃华医药、启迪药业、康惠制药等跟涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/09093650939013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000590","002349","BK0033","BK0102","BK0239","002107","002826","002317","BK0056","603139","BK0077","BK0188","BK0122"],"gpt_icon":0},{"id":"2542822820","title":"姚劲波A股首秀6.6亿拿下易明医药   58同城掉队分拆上市不顺引借壳猜想","url":"https://stock-news.laohu8.com/highlight/detail?id=2542822820","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542822820?lang=zh_cn&edition=full","pubTime":"2025-06-09 07:01","pubTimestamp":1749423660,"startTime":"0","endTime":"0","summary":"2020年，58同城私有化退市。本次交易完成后，姚劲波将取代高帆成为易明医药的实际控制人。2013年10月31日，姚劲波在美国纽交所敲响了58同城上市钟声。58同城美股上市后，借助资本之手，姚劲波的生活服务圈不断扩大。借壳上市的猜想毋庸置疑，姚劲波6.62亿元购买的易明医药，是一个“壳”。58同城私有化后，姚劲波频频分拆资产进行证券化，但并不算顺利。2020年，其营业收入7.11亿元，归母净利润亏损6.14亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-06-09/doc-inezmmiq6903198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0056","002826","399300","159982","BK0033"],"gpt_icon":0},{"id":"2541008842","title":"【易明医药：股票交易异常波动，连续两个交易日内日收盘价涨幅偏离值累计超20％】金融界6月8日消息，易明医药发布异动公告，公司股票于2025年6月5日、2025年6月6日连续两个交易日内日收盘价涨幅偏离值累计达到20％以上，属于股票交易异常波动情况。此前北京福好拟协议收购控股股东、实际控制人高帆持有的43,855,883股公司股份，占上市公司股份总数的23.00% ，公司已披露相关公告，本次权益变动事项尚存在不确定性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2541008842","media":"金融界","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541008842?lang=zh_cn&edition=full","pubTime":"2025-06-08 15:55","pubTimestamp":1749369326,"startTime":"0","endTime":"0","summary":"金融界6月8日消息，易明医药发布异动公告，公司股票于2025年6月5日、2025年6月6日连续两个交易日内日收盘价涨幅偏离值累计达到20％以上，属于股票交易异常波动情况。此前北京福好拟协议收购控股股东、实际控制人高帆持有的43,855,883股公司股份，占上市公司股份总数的23.00% ，公司已披露相关公告，本次权益变动事项尚存在不确定性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/08155550935499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0033","BK0239","002826","BK0056"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752146209672,"stockEarnings":[{"period":"1week","weight":-0.0181},{"period":"1month","weight":0.0362},{"period":"3month","weight":0.8718},{"period":"6month","weight":0.9008},{"period":"1year","weight":1.3626},{"period":"ytd","weight":0.7833}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0274},{"period":"3month","weight":0.0836},{"period":"6month","weight":0.1024},{"period":"1year","weight":0.1803},{"period":"ytd","weight":0.0422}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22007人(较上一季度减少37.25%)","perCapita":"7921股","listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","registeredCapital":"19067万元","survey":"　　西藏易明西雅医药科技股份有限公司的主营业务是糖尿病、心血管疾病等老年慢性病症治疗及妇科领域核心产品的开发和研究。公司的主要产品是品种米格列醇片（奥恬苹®）、红金消结片（美消丹®）、蒙脱石散（贝易平®）、醋氯芬酸肠溶片（维朴芬®）等。公司是中国心脑血管病诊疗产业技术创新战略联盟理事单位（西藏）、国家级科技企业孵化企业、西藏药学会第七届理事会理事单位、西藏经开区优秀企业、拉萨市绿色发展试点企业；子公司维奥制药是国家高新技术企业、四川省医药行业协会第三届理事单位、彭州市制造业企业20强。","listedPrice":6.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}